Keros Therapeutics, Inc. · NASDAQ:KROS

ExodusPoint Capital Management, LP reported a 6.30% stake in Keros Therapeutics, Inc. (Schedule 13G)

Event Nov 10, 2025 · Filed Nov 18, 2025

ExodusPoint Capital Management, LP reported a 6.30% stake in Keros Therapeutics, Inc., 1,907,899 shares, as a passive investor on Nov 10, 2025. Filed Nov 18, 2025 (Schedule 13G).

Stake
6.30%
Shares
1,907,899
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
ExodusPoint Capital Management, LP6.30%1,907,899
ExodusPoint Capital Partners GP, LLC6.30%1,907,899
Michael Gelband6.30%1,907,899

Source

View original at SEC

Related